Sooyun Lee

Title: Sooyun Lee: Innovator in Natural Killer Cell Therapy

Introduction

Sooyun Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cellular therapy, particularly in the development of natural killer (NK) cell treatments for cancer. With two patents to his name, Lee's work focuses on innovative methods for producing and utilizing NK cells as effective anti-cancer agents.

Latest Patents

Lee's latest patents include a method for mass producing natural killer cells and the use of these cells as anti-cancer agents. This method allows for the production of fresh NK cells with high purity in a short time. It also enables the creation of cold-preserved and thawed cryopreserved NK cells that maintain efficacy comparable to fresh NK cells. These NK cells have shown therapeutic effects against various cancers, including colorectal, lung, liver, pancreatic cancers, and leukemia. Additionally, Lee has developed a natural killer cell expressing an anti-cotinine chimeric antigen receptor (CAR) that specifically binds to cotinine. This CAR-expressing NK cell can effectively target tumor tissues, making it a promising candidate for gene therapy with a high anticancer effect.

Career Highlights

Sooyun Lee has worked with notable institutions such as the Korea Research Institute of Bioscience and Biotechnology and Seoul National University. His research has significantly advanced the understanding and application of NK cells in cancer therapy.

Collaborations

Lee has collaborated with esteemed colleagues, including In Pyo Choi and Tae-Don Kim, to further enhance the development of NK cell therapies.

Conclusion

Sooyun Lee's innovative work in the field of natural killer cell therapy positions him as a key figure in cancer treatment advancements. His patents reflect a commitment to improving therapeutic options for patients battling various forms of cancer.